These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of extensive doxorubicin hydrochloride extravasation injuries. Linder RM; Upton J; Osteen R J Hand Surg Am; 1983 Jan; 8(1):32-8. PubMed ID: 6827049 [TBL] [Abstract][Full Text] [Related]
3. Surgical management after doxorubicin and epirubicin extravasation. Heitmann C; Durmus C; Ingianni G J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616 [TBL] [Abstract][Full Text] [Related]
4. [Early and late treatment of iatrogenic injection damage]. von Heimburg D; Pallua N Chirurg; 1998 Dec; 69(12):1378-82. PubMed ID: 10023567 [TBL] [Abstract][Full Text] [Related]
5. Extravasation of chemotherapeutic agents. Hankin FM; Louis DS Am Fam Physician; 1985 Mar; 31(3):147-50. PubMed ID: 3976457 [TBL] [Abstract][Full Text] [Related]
6. [Soft-tissue defects on the dorsum of the hand by extravasation of the cytostatic agents: surgical options of treatment]. Damert HG; Lenz-Scharf O; Altmann S; Schneider W Handchir Mikrochir Plast Chir; 2007 Dec; 39(6):409-13. PubMed ID: 18058671 [TBL] [Abstract][Full Text] [Related]
7. Major intravenous extravasation injuries. Upton J; Mulliken JB; Murray JE Am J Surg; 1979 Apr; 137(4):497-506. PubMed ID: 426199 [No Abstract] [Full Text] [Related]
8. Histologic changes induced in skin by extravasation of doxorubicin (adriamycin). Bhawan J; Petry J; Rybak ME J Cutan Pathol; 1989 Jun; 16(3):158-63. PubMed ID: 2671070 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies. Dahlstrøm KK; Chenoufi HL; Daugaard S Cancer; 1990 Apr; 65(8):1722-6. PubMed ID: 2317755 [TBL] [Abstract][Full Text] [Related]
10. [Clinical manifestation of extravasation caused by infusion and its therapeutic management]. Altmann S; Damert HG; Schneider W Zentralbl Chir; 2014 Feb; 139(1):83-8. PubMed ID: 21598203 [TBL] [Abstract][Full Text] [Related]
13. High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion. Dorr RT; Dordal MS; Koenig LM; Taylor CW; McCloskey TM Cancer; 1989 Dec; 64(12):2462-4. PubMed ID: 2819656 [TBL] [Abstract][Full Text] [Related]
14. Adriamycin extravasation: surgical treatment and possible prevention of skin and soft-tissue injuries. Pitkänen J; Asko-Seljavaara S; Gröhn P; Sundell B; Heinonen E; Appelqvist P J Surg Oncol; 1983 Aug; 23(4):259-62. PubMed ID: 6876801 [TBL] [Abstract][Full Text] [Related]
16. [A patient with a severe injury of the back of the hand following extravasation of doxorubicin]. Wassenaar HA; Sonneveld P; Nooter K; Sizoo W Ned Tijdschr Geneeskd; 1984 Mar; 128(13):603-6. PubMed ID: 6371551 [No Abstract] [Full Text] [Related]
18. Versajet hydrosurgery system in the debridement of skin necrosis after Ca gluconate extravasation: report of 9 infantile cases. Sivrioğlu N; Irkören S Acta Orthop Traumatol Turc; 2014; 48(1):6-9. PubMed ID: 24643093 [TBL] [Abstract][Full Text] [Related]
19. Extravasation injuries. Rose RE; Felix R; Crawford-Sykes A; Venugopal R; Wharfe G; Arscott G West Indian Med J; 2008 Jan; 57(1):40-7. PubMed ID: 19565937 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of cutaneous ulcerations caused by adriamycin extravasation]. Friedhoffer H; Carramaschi F; Calonge H; Gansl R; Ferreira MC Rev Paul Med; 1988; 106(4):197-200. PubMed ID: 3256915 [No Abstract] [Full Text] [Related] [Next] [New Search]